Showing results (551-560 of 579) with videos related to
Sort By:
Pageof 58
Research and Practice in Thrombosis and Haemostasis|December 10, 2025
Hetrombopag for patients with persistent primary immune thrombocytopenia: a post hoc analysis of a multicenter, randomized phase Ⅲ trialHeng Mei, Xiaofan Liu, Yan Li, et al.Haematologica|March 23, 2023
Graft-versus-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMTRaynier Devillier, Dirk-Jan Eikema, Carlo Dufour, et al.Bone Marrow Transplantation|June 4, 2024
Prognostic factors impacting post-transplant outcomes in adult T-cell acute lymphoblastic leukemia: a registry-based study by the EBMT acute leukemia working partyJean El Cheikh, Maud Ngoya, Jacques-Emmanuel Galimard, et al.Microbial Cell Factories|November 28, 2021
A comprehensive approach to stool donor screening for faecal microbiota transplantation in ChinaJianquan He, Xingxiang He, Yonghui Ma, et al.Haematologica|May 18, 2023
Current use of androgens in bone marrow failure disorders: a report from the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow TransplantationSimona Pagliuca, Austin G Kulasekararaj, Dirk-Jan Eikema, et al.Journal of Hematology & Oncology|April 2, 2022
Chimeric antigen receptors containing the OX40 signalling domain enhance the persistence of T cells even under repeated stimulation with multiple myeloma target cellsJingwen Tan, Yujie Jia, Meixia Zhou, et al.Blood Cancer Journal|September 27, 2022
Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMTKavita Raj, Dirk-Jan Eikema, Vipul Sheth, et al.Haematologica|June 19, 2025
TET2 mutation does not impact the prognosis of adult acute myeloid leukemia patients receiving a hematopoietic stem cell transplantation in first remission: similar outcome following matched sibling and unrelated versus haploidentical donor transplants in a multi-center retrospective analysis from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationLin Li, Yishan Ye, Jacques-Emmanuel Galimard, et al.Hemasphere|August 18, 2025
Autologous stem cell transplantation in NK/T-cell lymphoma: Prognostic impact of EBV-DNA in a multinational cohort-A study by the EBMT Lymphoma Working PartyPhilipp Berning, Maud Ngoya, Won Seog Kim, et al.Bone Marrow Transplantation|January 31, 2024
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMTMeral Beksac, Diderik-Jan Eikema, Linda Koster, et al.Pageof 58